Virtual Matchmaking event on the Development and production of COVID-19 therapeutics

Second European Matchmaking event on the Development and production of COVID-19 therapeutics

On the 29 and 30 November, the European Commission is organising the Second Virtual Matchmaking Event on COVID-19 Therapeutics in partnership with the Council of European BioRegions (CEBR), the European Cluster Alliance (ECA) and the ECCP.

This event will aim to accelerate:

• The development of new and repurposed medicines for COVID-19 therapeutics
• The development of medicines used to treat the symptoms of COVID-19
• The production of disposable materials (e.g. single use systems), ingredients and raw materials required for the manufacture of medicinal products

It will also aim to mobilise the EU pharma manufacturing capacity for the production of medicines to treat and prevent COVID-19.

Companies interested in participating in the event must complete the event’s registration form by 18 November 2021 (23h59 CEST). Here you will also find details on who can participate, agenda and much more.

An informative preparatory webinar on the purpose of the event is held on November 17th. Register here.

Any questions can be addressed to Daniela Coutinho and Raquel Gonçalves, from the European Cluster Collaboration Platform at eumatchmaking@clustercollaboration.eu